Melanotan II user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: Melanotan II dosage in studies.

In short

Of 109 people, 62 (57%) said Melanotan II brought some benefit and 65 (60%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Melanotan2 (112 accounts) and r/Peptides (2), 23 Nov 2024 to 6 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about Melanotan II, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 28/30 (93%).

Whose accounts these are: routes mentioned: injection 36, nasal spray 15; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did Melanotan II help? The overall picture

Of 109 people, 38 (35%) reported benefit only, 24 (22%) both benefit and harm, 41 (38%) harm only and 6 (6%) neither.

Stopping. 7 people (6%) said they stopped or paused: 2 because of harms and 5 because they noticed no effect or for another reason.

Share = people / 109.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only3835%
Both benefit and harm2422%
Harm only4138%
Neither benefit nor harm66%

Most common reported benefits

Of 109 people. 62 (57%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Tan5147%
Less sunburn55%
Sexual desire or erection55%
Less appetite or weight loss33%
Other benefit87%

Share = people / 109.

Most common reported harms

Of 109 people. 65 (60%) mentioned some harm; 6 said explicitly they had none.

ReportedPeopleShare
Uneven or unwanted darkening (freckles, face, lips)2422%
Nausea or vomiting1817%
Flushing1211%
Mole changes or new moles76%
Prolonged or unwanted erection66%
Fatigue33%
Headache22%
Heart or blood pressure11%
Yawning or stretching11%
Other, rarer harm1514%
Harms mentioned but not named11%

Share = people / 109.

How severe were the harms?

Of the 64 people who described how strong a harm was, 41 (64%) described it as mild, 20 (31%) as clearly bothersome and 3 (5%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 64.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable4164%
Clearly bothersome: several days, sleep or work affected2031%
Severe: emergency visit, hospital or unable to function35%

Harms known from research and regulators: What are the side effects of melanotan II?

How long did people use Melanotan II?

64 of 109 people (59%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 64.
Stated length of usePeopleShare
Under a week2234%
1-4 weeks2539%
1-3 months914%
Over 3 months813%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

12 of 109 people (11%) used other substances at the same time. The most common: melanotan 1 (4), antihistamine (2), beta-carotene (2) and retatrutide (2). Then the account cannot tell which substance had the effect.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: Melanotan II dosage in studies. Legal status: Is melanotan II legal in Finland?

What can be concluded?

A tan was the intended and most often reported effect. The most common harm was unwanted or uneven darkening, and some described mole changes, which the accounts cannot assess.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: Melanotan II: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, GHK-Cu user experiences, PT-141 user experiences, Melanotan 1 user experiences, Glutathione user experiences, GLOW blend user experiences, KLOW blend user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.